Image Source: PexelsChemical Works of Gedeon Richter PLC (RGEDF) is a pharmaceutical company. The company focuses on developing and manufacturing gynecological, cardiovascular, and central nervous system products. It manufactures original, generic, and licensed medicines for therapeutic treatments.The company has two business segments namely, (1) a Pharmaceuticals segment doing the research and development, manufacturing, sales and marketing of its pharmaceutical products, and (2) a Wholesale and Retail segment dedicated to the products of the company.The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.The company was founded in 1901 and is headquartered in Budapest, Hungary.Three key data points gauge the Chemical Works of Gedeon Richter PLC or any dividend-paying firm.The key three are:(1) Price(2) Dividends(3) ReturnsThose three basic keys best tell whether any company has made, is making, and will make money.RGEDF PriceOver the past year, Richter’s share price increased about 25.5% from $19.80 to $24.85 as of Wednesday’s market close.If RGEDF trades in the range of $20.00 to $30.00 this next year, its recent $24.85 share price might rise to $25.70 by next year. Of course, Richter’s price could drop about the same $0.85 estimated amount or more.My annual upside estimate of $0.85 however, is about equal to the average annual share price gain over the past five years.RGEDF DividendChemical Works of Gedeon Richter PLC has paid variable Annual dividends since June 2015, except for 2018. Richter’s most recent dividend of $1.13 was declared on April 3, 2023, to shareholders of record on June 7th. The payout was made on June 15th.The forward-looking $1.13 annual dividend yields 4.56% at Wednesday’s $24.85 share price.RGEDF ReturnsTo put it all together, add the estimated annual dividend of $1.13 to the price upside of $0.85 to find a $1.98 gross gain.At Wednesday’s $24.85 share price, a little under $1000 would buy 40 shares.A $10 broker fee (if charged), paid half at purchase and half at sale, would cost us $0.25 per share.Subtracting that likely $0.25 brokerage cost from the $1.98 gross gain produces a net gain of $1.73 X 40 shares = $69.20 for a 6.9% estimated net gain.You might choose to pounce on the Chemical Works of Gedeon Richter PLC It is a 123-year-old Hungarian Pharmaceutical firm headquartered in Budapest.Furthermore, the estimated $45.60 of annual dividend income from $1k invested is about 1.84 times greater than Richter’s recent $24.85 single share price.The exact track of the Chemical Works of Gedeon Richter PLC’s ongoing future price and dividend will be determined by market action.Remember the true value of any stock is best realized through personal ownership of shares.More By This Author:Current Analysis: Pfizer
Current Analysis: Patterson
Current Analysis: Medical Facilities (MFCSF)
